Wikisage, the free encyclopedia of the second generation, is digital heritage

Aspirin: Difference between revisions

From Wikisage
Jump to navigation Jump to search
m (hide)
mNo edit summary
Line 4: Line 4:
<ref>[https://www.mdpi.com/2077-0383/8/1/104/htm Clopidogrel versus Ticagrelor for Secondary Prevention after Coronary Artery Bypass Grafting]</ref>
<ref>[https://www.mdpi.com/2077-0383/8/1/104/htm Clopidogrel versus Ticagrelor for Secondary Prevention after Coronary Artery Bypass Grafting]</ref>
[[File:Kawasaki_tongue_1.jpg|thumb]]
[[File:Kawasaki_tongue_1.jpg|thumb]]
==Kawasaki==
==[[Kawasaki disease|Kawasaki]]==


Protocols recommend AAs and intravenous immunoglubin; however many cases have be shown to be refractory  to this treatment  
Protocols recommend AAs and intravenous immunoglubin; however many cases have be shown to be refractory  to this treatment  

Revision as of 12:51, 24 January 2019

Aspirin is an NSAID [1] A recommendation of AAs-clopidogrel to maintain the patency of the stent following coronary intervention. Clopidogrel is a P2Y12 inhibiting platelet agent; the combination AAs Ticagrelor wasn´t better than clopidogrel+aspirin [2]

Kawasaki

Protocols recommend AAs and intravenous immunoglubin; however many cases have be shown to be refractory to this treatment [3]

Hutchinson Gliford Progeria

Low dosis Aspirin 2-3 mg/Kg body weight is recommended for prevention of cardiovascular and stroke complications [4]

ATC

Salicylic acid and derivates

  • Acetylsalicylic acid (INN)

N02BA01

Links

Level and variation on quality of care in China: a cross-sectional study for the acute myocardial infarction patients in tertiary hospitals in Beijing


Q18216 at Wikidata  Interwiki via Wikidata